Name: XENON PHARMACEUTICALS INC (XENE) Stock
Brand: XENON PHARMACEUTICALS INC
Rating: 6 (3 reviews)

XENE Latest News, Press Relases and Analysis

All

Press Releases

18 days ago - By: Xenon Pharmaceuticals Inc.

Xenon to Present at Upcoming Investor Conferences

20 days ago - By: Zacks Investment Research - Mentions: BEAM NBIX FOLD

Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus

21 days ago - By: Xenon Pharmaceuticals Inc.

Xenon Reports Third Quarter 2025 Financial Results & Business Update

21 days ago - By: Xenon Pharmaceuticals Inc.

Xenon Reports Third Quarter 2025 Financial Results & Business Update

24 days ago - By: Benzinga

Insights into Xenon Pharmaceuticals's Upcoming Earnings

21 days ago - By: Benzinga - Mentions: ON TIMB GT IRMD ...

Earnings Scheduled For November 3, 2025

a month ago - By: Xenon Pharmaceuticals Inc.

Xenon to Report Q3 2025 Financial Results on November 3, 2025

a month ago - By: Xenon Pharmaceuticals Inc.

Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer

a month ago - By: Xenon Pharmaceuticals Inc.

Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer

2 months ago - By: Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Xenon Pharmaceuticals Inc.

Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain

2 months ago - By: Xenon Pharmaceuticals Inc.

Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain

2 months ago - By: Design Therapeutics, Inc. - Mentions: DSGN CMPS

Design Therapeutics Appoints Justin Gover to Board of Directors

3 months ago - By: Zacks Investment Research - Mentions: NTLA

Why Is Xenon Pharmaceuticals (XENE) Up 4.2% Since Last Earnings Report?

3 months ago - By: Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Zacks Investment Research - Mentions: NBIX CRMD ALVO

Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus

3 months ago - By: Xenon Pharmaceuticals Inc.

Xenon Reports Second Quarter 2025 Financial Results & Business Update

3 months ago - By: Xenon Pharmaceuticals Inc.

Xenon Reports Second Quarter 2025 Financial Results & Business Update

4 months ago - By: Xenon Pharmaceuticals Inc.

Xenon to Report Q2 2025 Financial Results on August 11, 2025

4 months ago - By: Xenon Pharmaceuticals Inc.

Xenon to Report Q2 2025 Financial Results on August 11, 2025

4 months ago - By: Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 months ago - By: Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Stocktwits - Mentions: BIIB SRPT ALKS BHVN ...